Tag: anti-IgE
Biologics in Severe Asthma: How Anti-IgE and Anti-IL-5 Therapies Change the Game
Anti-IgE and anti-IL-5 biologics are transforming severe asthma care by targeting specific immune pathways. Learn how omalizumab, mepolizumab, and benralizumab reduce flare-ups, cut steroid use, and restore quality of life for those who don’t respond to standard treatments.
read morerecent posts
Patent exclusivity and market exclusivity are two separate legal tools that protect drug prices. Patents cover inventions; FDA exclusivity blocks generics using clinical data-even without a patent. Understanding the difference explains why some drugs stay expensive long after patents expire.
Published ON: 7 FebIBS causes recurring abdominal pain, bloating, and bowel changes. Learn the real symptoms, common triggers like food and stress, and proven medication options for IBS-D, IBS-C, and mixed types - plus non-drug strategies that work.
Published ON: 2 FebLearn how to safely handle, store, and avoid exposure to chemotherapy at home. Essential guidelines for patients and caregivers on protecting yourself, family, and pets during home cancer treatment.
Published ON: 1 FebAnti-IgE and anti-IL-5 biologics are transforming severe asthma care by targeting specific immune pathways. Learn how omalizumab, mepolizumab, and benralizumab reduce flare-ups, cut steroid use, and restore quality of life for those who don’t respond to standard treatments.
Published ON: 13 FebDTC prescription drug ads in the U.S. drive higher demand for branded medications, often overshadowing equally effective generics. Research shows ads increase prescriptions but also lead to inappropriate requests and higher costs. Learn how advertising influences patient decisions and healthcare outcomes.
Published ON: 6 Feb